SAMANTHA SHENOY: Open Payments
NPI 1083959811 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$17,646 in 32 payments from 9 companies in 2025. Trend: 2023 $1,787 · 2024 $10,135 · 2025 $17,646
Travel & lodging: $7,404Consulting: $6,918Grant: $2,171Food & beverage: $728Speaker / faculty: $426
| Company | Payments | Amount |
|---|---|---|
| Janssen Global Services, LLC | 8 | $9,270 |
| Janssen Biotech, Inc. | 7 | $4,780 |
| GENZYME CORPORATION | 4 | $2,171 |
| Regeneron Pharmaceuticals, Inc. | 1 | $524 |
| TAIHO ONCOLOGY, INC. | 4 | $382 |
| AstraZeneca Pharmaceuticals LP | 2 | $252 |
| Legend Biotech USA Inc. | 4 | $230 |
| ABBVIE INC. | 1 | $21 |
| Adaptive Biotechnologies Corporation | 1 | $17 |
Products named: CARVYKTI, DARZALEX, LYNOZYFIC, RYBREVANT, IMBRUVICA, clonoSEQ.
Industry payments across CA — which companies pay providers there.
